Design Pharmaceuticals
Robert Nicol is the Director of Technology Development at the Broad Institute of MIT and Harvard.
Robert's research group develops tools to engineer biology across three core areas: massively parallel DNA synthesis, biomolecule library generation, and ultra-high throughput methods to screen these libraries for machine learning. These tools require integration of systems engineering, microfluidics, semiconductors, synthetic biology, and sequencing. Robert has been an Investigator on multiple large scale advanced biotechnology development programs for DARPA, IARPA, and NIH. Robert is also the co-founder of multiple biotechnology companies focused on applying these tools to create advanced therapeutics for the benefit of patients.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Design Pharmaceuticals
Design Pharma has a unique suite of proprietary technologies that enable the discovery and biosynthetic production of drug candidates.